Partial Modified Blair Incision on Benign Tumor Parotidectomy Scar's Characteristics — MiniBlair

Salivary Gland Tumor Clinical Trial

Official title:
Effect of Parotid Mass Location on Benign Tumor Parotidectomy Scar's Characteristics

Status Completed

Clinical Trial Summary

Parotidectomy is the treatment of choice for tumors in the parotid gland, with the modified Blair is the most common incision used. In our medical center, the incision is tailored to the size and location of the specific parotid tumor. This retrospective analysis aims to determine the incidence of complications and to assess the relation between the mass and scar characteristics in patients who had undergone parotidectomy.

Clinical Trial Description

The scar characteristics of patient who had undergone parotidectomy for benign neoplasms at our medical center between 2013 and 2019 will be evaluated. Patients will complete a questionnaire regarding the occurrence of complications. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04970875
Study type	Observational
Source	Western Galilee Hospital-Nahariya
Contact
Status	Completed
Phase
Start date	June 1, 2021
Completion date	June 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03602079` - Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene	Phase 1/Phase 2
Recruiting	`NCT06047236` - Immune Biomarker Study for Salivary Gland Carcinoma
Active, not recruiting	`NCT05581979` - PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
Active, not recruiting	`NCT04249947` - P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)	Phase 1
Completed	`NCT06034782` - Diagnostic Accuracy of Fine Needle Aspiration in Patients With Salivary Gland Tumors.
Recruiting	`NCT04452162` - Physiologic MR Imaging of Salivary Gland Tumors	N/A